ScholarIQanswers from OpenAlex

High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma

PaperCitations, authors & open-access status

High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma is a paper indexed in ScholarIQ from OpenAlex.

How many citations does High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma have?

ScholarIQcitation count

High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma has 323 citations in the OpenAlex counts ScholarIQ stores.

When was High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma published?

ScholarIQyear

High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma has 2004 year in the ScholarIQ index.

What is the open-access status of High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma?

ScholarIQoa status

High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma has bronze oa status in the ScholarIQ index.

What is the DOI of High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma?

ScholarIQdoi

The DOI for High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma is on the source record.

What is the PMID of High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma?

ScholarIQpmid

The PMID for High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma is on the source record.

What is the OpenAlex record for High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma?

ScholarIQopenalex

The OpenAlex for High‐dose methotrexate‐induced nephrotoxicity in patients with osteosarcoma is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial